DexCom, Inc. (DXCM) Stock Overview
Explore DexCom, Inc.’s financial performance, market position, analyst ratings, and future outlook.
DexCom, Inc. (DXCM)
Key Financials
Key Financials
Market Cap
29.6B
P/E Ratio
31.84
EPS (TTM)
$2.33
ROE
0.34%
DXCM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of DexCom, Inc. (DXCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 59.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $60.97.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 31.84 and a market capitalization of 29.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.